Pharmaceutical Antitrust – An Analysis of US and EU Law

 
December 06, 2023

Mélanie Thill-Tayara and George G. Gordon (eds.)


Forewords by Alden Abott (George Mason University) and
Ian S. Forrester KC (ex-General Court of the European Union)


In an era of unprecedented innovation in life sciences, where breakthroughs in pharmaceuticals, biotechnology, and healthcare are shaping global health and economies, “Pharmaceutical Antitrust: An Analysis of US and EU Law” is an indispensable guide.

Edited by Mélanie Thill-Tayara and George G. Gordon, esteemed experts in antitrust law, this book offers a comprehensive examination of how competition laws are applied in the life sciences sector in the United States and the European Union.

The book provides in-depth analysis of and practical insights regarding the effect of the complex interplay of IP, regulatory frameworks, and competition principles on issues related to marketing authorizations, exclusivities, patent acquisition and enforcement, mergers and acquisitions, collaboration agreements, pricing strategies, and distribution arrangements.

Each chapter provides invaluable insights into the intricacies of antitrust, international cooperation among antitrust authorities, and the analysis of market dynamics within the pharmaceutical arena. This book is an indispensable companion for legal professionals, academics, regulators, and executives operating in the complex world of pharmaceuticals and antitrust law.

It is tailored for both non-antitrust specialists in the life sciences sector who are seeking to understand the competition law issues facing the industry, and for antitrust specialists who represent life sciences clients on these issues.